Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial

Overview of attention for article published in Annals of Internal Medicine, March 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

news: 11 news outlets
blogs: 1 blog
twitter: 16 X users

facebook: 1 Facebook page
bluesky: 1 Bluesky user
podcasts: 1 podcast

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 19 X posts from 16 X users, with an upper bound of 109,943 followers.

Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial | Annals of Internal Medicine✅✅✅ https://t.co/glMo4A2glY

RT @drjohnmorley: Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Random…

RT @AnnalsofIM: #ICYMI: analysis of the ASPREE trial found no clear harm or benefit to continuing or stopping aspirin use in older adults w…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 15 additional X posts.